Terms: = Prostate cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Treatment
21 results:
1. Decision aids for people facing health treatment or screening decisions.
Stacey D; Lewis KB; Smith M; Carley M; Volk R; Douglas EE; Pacheco-Brousseau L; Finderup J; Gunderson J; Barry MJ; Bennett CL; Bravo P; Steffensen K; Gogovor A; Graham ID; Kelly SE; Légaré F; Sondergaard H; Thomson R; Trenaman L; Trevena L
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD001431. PubMed ID: 38284415
[TBL] [Abstract] [Full Text] [Related]
2. A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer.
Ipsen MB; Sørensen EMG; Thomsen EA; Weiss S; Haldrup J; Dalby A; Palmfeldt J; Bross P; Rasmussen M; Fredsøe J; Klingenberg S; Jochumsen MR; Bouchelouche K; Ulhøi BP; Borre M; Mikkelsen JG; Sørensen KD
Oncogene; 2022 Sep; 41(37):4271-4281. PubMed ID: 35933519
[TBL] [Abstract] [Full Text] [Related]
3. Olaparib tolerability and common adverse-event management in patients with metastatic castration-resistant prostate cancer: Further analyses from the PROfound study.
Roubaud G; Özgüroğlu M; Penel N; Matsubara N; Mehra N; Kolinsky MP; Procopio G; Feyerabend S; Joung JY; Gravis G; Nishimura K; Gedye C; Padua C; Shore N; Thiery-Vuillemin A; Saad F; van Alphen R; Carducci MA; Desai C; Brickel N; Poehlein C; Del Rosario P; Fizazi K
Eur J Cancer; 2022 Jul; 170():73-84. PubMed ID: 35598359
[TBL] [Abstract] [Full Text] [Related]
4. Association Between Granulocyte Colony-Stimulating Factor (G-CSF) Use and Myelodysplastic Syndrome (mds) or Acute Myeloid Leukemia (AML) Among Elderly Patients with Breast, Lung, or prostate cancer.
Danese MD; Schenfeld J; Shaw J; Gawade P; Balasubramanian A; Kelsh M; Hernandez RK; Lyman G
Adv Ther; 2022 Jun; 39(6):2778-2795. PubMed ID: 35430673
[TBL] [Abstract] [Full Text] [Related]
5. Fast robust optimization of proton PBS arc therapy plans using early energy layer selection and spot assignment.
Engwall E; Battinelli C; Wase V; Marthin O; Glimelius L; Bokrantz R; Andersson B; Fredriksson A
Phys Med Biol; 2022 Mar; 67(6):. PubMed ID: 35172282
[No Abstract] [Full Text] [Related]
6. Changes in functional status associated with radiation for prostate cancer in older veterans.
Ursem C; Diaz-Ramirez LG; Boscardin J; Lee S
J Geriatr Oncol; 2021 Jun; 12(5):808-812. PubMed ID: 33388282
[TBL] [Abstract] [Full Text] [Related]
7. B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review.
Sinit RB; Hwang DG; Vishnu P; Peterson JF; Aboulafia DM
BMC Cancer; 2019 Nov; 19(1):1147. PubMed ID: 31775673
[TBL] [Abstract] [Full Text] [Related]
8. Alpha-blockers with or without phosphodiesterase type 5 inhibitor for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis.
Zhang J; Li X; Yang B; Wu C; Fan Y; Li H
World J Urol; 2019 Jan; 37(1):143-153. PubMed ID: 29948047
[TBL] [Abstract] [Full Text] [Related]
9. Decision aids for people facing health treatment or screening decisions.
Stacey D; Légaré F; Lewis K; Barry MJ; Bennett CL; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Thomson R; Trevena L
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD001431. PubMed ID: 28402085
[TBL] [Abstract] [Full Text] [Related]
10. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for prostate cancer: A Population-Based Study.
Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
[TBL] [Abstract] [Full Text] [Related]
11. Accessibility and Quality of Online cancer-Related Clinical Trial Information for Naïve Searchers.
Abel GA; Cronin AM; Earles K; Gray SW
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1629-31. PubMed ID: 26265204
[TBL] [Abstract] [Full Text] [Related]
12. Radiotherapy- and chemotherapy-induced myelodysplasia syndrome: a nationwide population-based nested case-control study.
Sun LM; Lin CL; Lin MC; Liang JA; Kao CH
Medicine (Baltimore); 2015 May; 94(17):e737. PubMed ID: 25929909
[TBL] [Abstract] [Full Text] [Related]
13. Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation.
Mukherjee S; Reddy CA; Ciezki JP; Abdel-Wahab M; Tiu RV; Copelan E; Advani AA; Saunthararajah Y; Paulic K; Hobson S; Maciejewski JP; Bolwell BJ; Kalaycio M; Dreicer R; Klein EA; Sekeres MA
J Natl Cancer Inst; 2014 Mar; 106(3):djt462. PubMed ID: 24577815
[TBL] [Abstract] [Full Text] [Related]
14. A comparative study of glycoproteomes in androgen-sensitive and -independent prostate cancer cell lines.
Drabik A; Ciołczyk-Wierzbicka D; Dulińska-Litewka J; Bodzoń-Kułakowska A; Suder P; Silberring J; Laidler P
Mol Cell Biochem; 2014 Jan; 386(1-2):189-98. PubMed ID: 24104455
[TBL] [Abstract] [Full Text] [Related]
15. [Localised prostate cancer: the PREFERE trial].
Stöckle M; Bussar-Maatz R
Z Evid Fortbild Qual Gesundhwes; 2012; 106(5):333-5; discussion 335. PubMed ID: 22818151
[TBL] [Abstract] [Full Text] [Related]
16. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
[TBL] [Abstract] [Full Text] [Related]
17. Chromatin structural elements and chromosomal translocations in leukemia.
Zhang Y; Rowley JD
DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
[TBL] [Abstract] [Full Text] [Related]
18. DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.
Rüter B; Wijermans PW; Lübbert M
Int J Hematol; 2004 Aug; 80(2):128-35. PubMed ID: 15481440
[TBL] [Abstract] [Full Text] [Related]
19. Decitabine: 2'-deoxy-5-azacytidine, Aza dC, DAC, dezocitidine, NSC 127716.
Drugs R D; 2003; 4(6):352-8. PubMed ID: 14584964
[TBL] [Abstract] [Full Text] [Related]
20. PC-SPES decreases proliferation and induces differentiation and apoptosis of human acute myeloid leukemia cells.
Ikezoe T; Chen S; Saito T; Asou H; Kyo T; Tanosaki S; Heber D; Taguchi H; Koeffler HP
Int J Oncol; 2003 Oct; 23(4):1203-11. PubMed ID: 12964005
[TBL] [Abstract] [Full Text] [Related]
[Next]
